nodes	percent_of_prediction	percent_of_DWPC	metapath
Tripelennamine—CYP2D6—schizophrenia	0.933	1	CbGaD
Tripelennamine—Orphenadrine—GRIN2D—schizophrenia	0.000824	0.0478	CrCbGaD
Tripelennamine—Tropicamide—CHRM1—schizophrenia	0.000786	0.0456	CrCbGaD
Tripelennamine—Pargyline—MAOA—schizophrenia	0.000648	0.0376	CrCbGaD
Tripelennamine—Doxylamine—CHRM1—schizophrenia	0.00064	0.0372	CrCbGaD
Tripelennamine—Alverine—HTR1A—schizophrenia	0.000619	0.0359	CrCbGaD
Tripelennamine—Captodiame—DRD3—schizophrenia	0.0006	0.0348	CrCbGaD
Tripelennamine—Orphenadrine—GRIN1—schizophrenia	0.000556	0.0323	CrCbGaD
Tripelennamine—Amitriptyline—NTRK2—schizophrenia	0.000556	0.0322	CrCbGaD
Tripelennamine—Benzphetamine—SLC18A2—schizophrenia	0.000514	0.0298	CrCbGaD
Tripelennamine—Captodiame—HTR2C—schizophrenia	0.000504	0.0293	CrCbGaD
Tripelennamine—Disopyramide—CHRM1—schizophrenia	0.000485	0.0282	CrCbGaD
Tripelennamine—Bepridil—CACNA1C—schizophrenia	0.000442	0.0256	CrCbGaD
Tripelennamine—Brompheniramine—CHRM1—schizophrenia	0.000361	0.0209	CrCbGaD
Tripelennamine—Doxepin—HTR6—schizophrenia	0.000324	0.0188	CrCbGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—schizophrenia	0.000322	0.0065	CbGpPWpGaD
Tripelennamine—Rosiglitazone—CYP1A2—schizophrenia	0.000321	0.0186	CrCbGaD
Tripelennamine—Methadone—HTR3A—schizophrenia	0.000311	0.0181	CrCbGaD
Tripelennamine—HRH1—G alpha (q) signalling events—CHRM1—schizophrenia	0.000293	0.00592	CbGpPWpGaD
Tripelennamine—CYP2D6—Melatonin metabolism and effects—APOE—schizophrenia	0.000292	0.0059	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—GRM5—schizophrenia	0.000273	0.00551	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAAR6—schizophrenia	0.000263	0.00532	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM1—schizophrenia	0.000262	0.0053	CbGpPWpGaD
Tripelennamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.000259	0.00523	CbGpPWpGaD
Tripelennamine—HRH1—IL-4 Signaling Pathway—FOS—schizophrenia	0.000258	0.0052	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR6—schizophrenia	0.000257	0.00518	CbGpPWpGaD
Tripelennamine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.000256	0.00517	CbGpPWpGaD
Tripelennamine—CYP2D6—Melatonin metabolism and effects—GSK3B—schizophrenia	0.000253	0.00511	CbGpPWpGaD
Tripelennamine—Imipramine—HTR6—schizophrenia	0.000252	0.0146	CrCbGaD
Tripelennamine—Chlorphenamine—SLC6A3—schizophrenia	0.000252	0.0146	CrCbGaD
Tripelennamine—Amitriptyline—HTR6—schizophrenia	0.00025	0.0145	CrCbGaD
Tripelennamine—HRH1—G alpha (q) signalling events—CCK—schizophrenia	0.000249	0.00504	CbGpPWpGaD
Tripelennamine—Rosiglitazone—CYP2D6—schizophrenia	0.000248	0.0144	CrCbGaD
Tripelennamine—Mepyramine—CYP2D6—schizophrenia	0.000246	0.0143	CrCbGaD
Tripelennamine—Cyclobenzaprine—CYP1A2—schizophrenia	0.000245	0.0142	CrCbGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—schizophrenia	0.000244	0.00492	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—CCKAR—schizophrenia	0.000239	0.00483	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—NTS—schizophrenia	0.000238	0.00481	CbGpPWpGaD
Tripelennamine—Doxepin—CHRM1—schizophrenia	0.000233	0.0135	CrCbGaD
Tripelennamine—CYP2D6—Biological oxidations—CYP26B1—schizophrenia	0.000229	0.00462	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM1—schizophrenia	0.000227	0.00458	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—CYP26B1—schizophrenia	0.000225	0.00455	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—schizophrenia	0.000223	0.0045	CbGpPWpGaD
Tripelennamine—Aprindine—CYP2D6—schizophrenia	0.000222	0.0129	CrCbGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR6—schizophrenia	0.00022	0.00444	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—schizophrenia	0.000214	0.00432	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—FZD3—schizophrenia	0.000213	0.00431	CbGpPWpGaD
Tripelennamine—Benzphetamine—SLC6A3—schizophrenia	0.000213	0.0124	CrCbGaD
Tripelennamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	0.00021	0.00424	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—OXT—schizophrenia	0.000209	0.00422	CbGpPWpGaD
Tripelennamine—Promazine—CHRM1—schizophrenia	0.000207	0.012	CrCbGaD
Tripelennamine—Cyclobenzaprine—HTR2A—schizophrenia	0.000207	0.012	CrCbGaD
Tripelennamine—CYP2D6—Biological oxidations—GCLM—schizophrenia	0.000204	0.00411	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—TAAR6—schizophrenia	0.000201	0.00405	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—GRM2—schizophrenia	0.000201	0.00405	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—NPS—schizophrenia	0.000198	0.004	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—HTR2C—schizophrenia	0.000194	0.00392	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM1—schizophrenia	0.000194	0.00392	CbGpPWpGaD
Tripelennamine—Cyclobenzaprine—CYP2D6—schizophrenia	0.000189	0.011	CrCbGaD
Tripelennamine—Chlorphenamine—SLC6A4—schizophrenia	0.000188	0.0109	CrCbGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—schizophrenia	0.000187	0.00377	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—CCKAR—schizophrenia	0.000185	0.00373	CbGpPWpGaD
Tripelennamine—Promazine—DRD4—schizophrenia	0.000184	0.0107	CrCbGaD
Tripelennamine—Imipramine—CHRM1—schizophrenia	0.000181	0.0105	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—NTS—schizophrenia	0.000181	0.00366	CbGpPWpGaD
Tripelennamine—Amitriptyline—CHRM1—schizophrenia	0.00018	0.0105	CrCbGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—schizophrenia	0.000179	0.00362	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—schizophrenia	0.000177	0.00358	CbGpPWpGaD
Tripelennamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.000175	0.00353	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—schizophrenia	0.000174	0.00351	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—GRM3—schizophrenia	0.000171	0.00345	CbGpPWpGaD
Tripelennamine—HRH1—IL-4 Signaling Pathway—EP300—schizophrenia	0.000171	0.00344	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR6—schizophrenia	0.000167	0.00338	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.000165	0.00334	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—schizophrenia	0.000162	0.00326	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.000158	0.0032	CbGpPWpGaD
Tripelennamine—Carbinoxamine—CYP2D6—schizophrenia	0.000156	0.00903	CrCbGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	0.000155	0.00314	CbGpPWpGaD
Tripelennamine—Promazine—DRD1—schizophrenia	0.000155	0.00902	CrCbGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.000154	0.0031	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	0.00015	0.00303	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	0.00015	0.00303	CbGpPWpGaD
Tripelennamine—Doxepin—HTR2C—schizophrenia	0.00015	0.00868	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—CHRM1—schizophrenia	0.000148	0.00299	CbGpPWpGaD
Tripelennamine—Imipramine—HTR7—schizophrenia	0.000147	0.00856	CrCbGaD
Tripelennamine—Tamoxifen—ESR1—schizophrenia	0.000147	0.00853	CrCbGaD
Tripelennamine—Amitriptyline—HTR7—schizophrenia	0.000147	0.0085	CrCbGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	0.000145	0.00294	CbGpPWpGaD
Tripelennamine—Doxepin—HTR1A—schizophrenia	0.000145	0.00843	CrCbGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.000143	0.0029	CbGpPWpGaD
Tripelennamine—Amitriptyline—HTR1B—schizophrenia	0.000142	0.00824	CrCbGaD
Tripelennamine—HRH1—GPCR downstream signaling—DGKI—schizophrenia	0.000142	0.00286	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	0.000141	0.00285	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.000138	0.0028	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.000138	0.0028	CbGpPWpGaD
Tripelennamine—Amitriptyline—DRD3—schizophrenia	0.000138	0.008	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—GRM5—schizophrenia	0.000138	0.00278	CbGpPWpGaD
Tripelennamine—Bepridil—CYP2D6—schizophrenia	0.000137	0.00798	CrCbGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.000135	0.00272	CbGpPWpGaD
Tripelennamine—Brompheniramine—CYP2D6—schizophrenia	0.000135	0.00782	CrCbGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.000133	0.00269	CbGpPWpGaD
Tripelennamine—Promazine—HTR2C—schizophrenia	0.000133	0.00772	CrCbGaD
Tripelennamine—Chlorphenamine—CYP2D6—schizophrenia	0.000132	0.00768	CrCbGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	0.000132	0.00266	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.000132	0.00266	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.000131	0.00265	CbGpPWpGaD
Tripelennamine—Imipramine—SLC6A3—schizophrenia	0.000129	0.00749	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—DGKI—schizophrenia	0.000129	0.0026	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.000129	0.0026	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.000129	0.0026	CbGpPWpGaD
Tripelennamine—Dextropropoxyphene—CYP2D6—schizophrenia	0.000128	0.00741	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—CCK—schizophrenia	0.000126	0.00254	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.000125	0.00252	CbGpPWpGaD
Tripelennamine—Doxepin—SLC6A4—schizophrenia	0.000124	0.00719	CrCbGaD
Tripelennamine—Doxepin—DRD2—schizophrenia	0.000123	0.00715	CrCbGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.000121	0.00244	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CCKAR—schizophrenia	0.000121	0.00244	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—HTR2A—schizophrenia	0.000119	0.00241	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PPP1R1B—schizophrenia	0.000118	0.00238	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—ADORA2A—schizophrenia	0.000117	0.00236	CbGpPWpGaD
Tripelennamine—Imipramine—HTR2C—schizophrenia	0.000116	0.00676	CrCbGaD
Tripelennamine—Diphenhydramine—CYP1A2—schizophrenia	0.000116	0.00675	CrCbGaD
Tripelennamine—Amitriptyline—HTR2C—schizophrenia	0.000116	0.00671	CrCbGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.000116	0.00233	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—TAAR6—schizophrenia	0.000113	0.00229	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GRM2—schizophrenia	0.000113	0.00229	CbGpPWpGaD
Tripelennamine—Tamoxifen—CYP1A2—schizophrenia	0.000113	0.00657	CrCbGaD
Tripelennamine—Imipramine—HTR1A—schizophrenia	0.000113	0.00656	CrCbGaD
Tripelennamine—Doxepin—CYP1A2—schizophrenia	0.000113	0.00655	CrCbGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.000113	0.00228	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.000113	0.00228	CbGpPWpGaD
Tripelennamine—Amitriptyline—HTR1A—schizophrenia	0.000112	0.00652	CrCbGaD
Tripelennamine—Methadone—CYP1A2—schizophrenia	0.000112	0.00652	CrCbGaD
Tripelennamine—CYP2D6—Biological oxidations—CYP1A2—schizophrenia	0.000112	0.00225	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—CYP1A2—schizophrenia	0.00011	0.00222	CbGpPWpGaD
Tripelennamine—Promazine—DRD2—schizophrenia	0.00011	0.00636	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—FZD3—schizophrenia	0.00011	0.00221	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—NPY—schizophrenia	0.000109	0.00221	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	0.000107	0.00215	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—OXT—schizophrenia	0.000105	0.00213	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR1B—schizophrenia	0.000105	0.00213	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—NGEF—schizophrenia	0.000105	0.00212	CbGpPWpGaD
Tripelennamine—HRH1—IL-4 Signaling Pathway—AKT1—schizophrenia	0.000103	0.00208	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PPP3CC—schizophrenia	0.000103	0.00208	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—TAAR6—schizophrenia	0.000103	0.00208	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GRM2—schizophrenia	0.000103	0.00208	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—NTS—schizophrenia	0.000103	0.00207	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR1A—schizophrenia	0.000101	0.00205	CbGpPWpGaD
Tripelennamine—Promazine—CYP1A2—schizophrenia	0.0001	0.00582	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—NPS—schizophrenia	9.99e-05	0.00202	CbGpPWpGaD
Tripelennamine—Bepridil—ABCB1—schizophrenia	9.81e-05	0.0057	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—DRD1—schizophrenia	9.8e-05	0.00198	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR2C—schizophrenia	9.8e-05	0.00198	CbGpPWpGaD
Tripelennamine—Imipramine—SLC6A4—schizophrenia	9.65e-05	0.0056	CrCbGaD
Tripelennamine—HRH1—GPCR downstream signaling—GRM3—schizophrenia	9.64e-05	0.00195	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—RGS4—schizophrenia	9.64e-05	0.00195	CbGpPWpGaD
Tripelennamine—Imipramine—DRD2—schizophrenia	9.59e-05	0.00557	CrCbGaD
Tripelennamine—Amitriptyline—SLC6A4—schizophrenia	9.59e-05	0.00556	CrCbGaD
Tripelennamine—Amitriptyline—DRD2—schizophrenia	9.53e-05	0.00553	CrCbGaD
Tripelennamine—Doxepin—HTR2A—schizophrenia	9.53e-05	0.00553	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—NGEF—schizophrenia	9.53e-05	0.00192	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—DRD3—schizophrenia	9.49e-05	0.00192	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR6—schizophrenia	9.46e-05	0.00191	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—COMT—schizophrenia	9.35e-05	0.00189	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—NTS—schizophrenia	9.31e-05	0.00188	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—GSTP1—schizophrenia	9.31e-05	0.00188	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—MAOA—schizophrenia	9.29e-05	0.00188	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—COMT—schizophrenia	9.22e-05	0.00186	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	9.21e-05	0.00186	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—DRD4—schizophrenia	9.21e-05	0.00186	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—GSTP1—schizophrenia	9.18e-05	0.00185	CbGpPWpGaD
Tripelennamine—Diphenhydramine—CYP2D6—schizophrenia	8.98e-05	0.00521	CrCbGaD
Tripelennamine—HRH1—GPCR ligand binding—CNR1—schizophrenia	8.8e-05	0.00178	CbGpPWpGaD
Tripelennamine—Imipramine—CYP1A2—schizophrenia	8.78e-05	0.0051	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—GRM3—schizophrenia	8.75e-05	0.00177	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—RGS4—schizophrenia	8.75e-05	0.00177	CbGpPWpGaD
Tripelennamine—Tamoxifen—CYP2D6—schizophrenia	8.74e-05	0.00507	CrCbGaD
Tripelennamine—Amitriptyline—CYP1A2—schizophrenia	8.73e-05	0.00507	CrCbGaD
Tripelennamine—Doxepin—CYP2D6—schizophrenia	8.71e-05	0.00506	CrCbGaD
Tripelennamine—Methadone—CYP2D6—schizophrenia	8.67e-05	0.00503	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR6—schizophrenia	8.59e-05	0.00174	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR7—schizophrenia	8.58e-05	0.00173	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—DRD2—schizophrenia	8.58e-05	0.00173	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—GSTM1—schizophrenia	8.55e-05	0.00173	CbGpPWpGaD
Tripelennamine—Promazine—HTR2A—schizophrenia	8.47e-05	0.00491	CrCbGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—GSTM1—schizophrenia	8.44e-05	0.0017	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CHRM1—schizophrenia	8.36e-05	0.00169	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—IL3RA—schizophrenia	8.15e-05	0.00165	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PRODH—schizophrenia	8e-05	0.00162	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	7.89e-05	0.00159	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GRM5—schizophrenia	7.77e-05	0.00157	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DGKI—schizophrenia	7.61e-05	0.00154	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CHRM1—schizophrenia	7.59e-05	0.00153	CbGpPWpGaD
Tripelennamine—Imipramine—HTR2A—schizophrenia	7.41e-05	0.0043	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—IL3RA—schizophrenia	7.4e-05	0.00149	CbGpPWpGaD
Tripelennamine—Amitriptyline—HTR2A—schizophrenia	7.37e-05	0.00428	CrCbGaD
Tripelennamine—HRH1—GPCR downstream signaling—CCK—schizophrenia	7.11e-05	0.00144	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GRM5—schizophrenia	7.06e-05	0.00143	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PPP1R1B—schizophrenia	6.96e-05	0.00141	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PDE4B—schizophrenia	6.93e-05	0.0014	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CCKAR—schizophrenia	6.81e-05	0.00138	CbGpPWpGaD
Tripelennamine—Imipramine—CYP2D6—schizophrenia	6.78e-05	0.00393	CrCbGaD
Tripelennamine—Amitriptyline—CYP2D6—schizophrenia	6.74e-05	0.00391	CrCbGaD
Tripelennamine—HRH1—GPCR downstream signaling—ADORA2A—schizophrenia	6.61e-05	0.00133	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MPC2—schizophrenia	6.52e-05	0.00132	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FZD3—schizophrenia	6.47e-05	0.00131	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CCK—schizophrenia	6.45e-05	0.0013	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PDE4B—schizophrenia	6.29e-05	0.00127	CbGpPWpGaD
Tripelennamine—Tamoxifen—ABCB1—schizophrenia	6.24e-05	0.00362	CrCbGaD
Tripelennamine—Doxepin—ABCB1—schizophrenia	6.22e-05	0.00361	CrCbGaD
Tripelennamine—Methadone—ABCB1—schizophrenia	6.19e-05	0.00359	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—CCKAR—schizophrenia	6.19e-05	0.00125	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—NPY—schizophrenia	6.17e-05	0.00125	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FES—schizophrenia	6.08e-05	0.00123	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PPP3CC—schizophrenia	6.08e-05	0.00123	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRM2—schizophrenia	6.08e-05	0.00123	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TAAR6—schizophrenia	6.08e-05	0.00123	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PLCH2—schizophrenia	6.06e-05	0.00122	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—HTR2A—schizophrenia	6.01e-05	0.00121	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ADORA2A—schizophrenia	6e-05	0.00121	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR1B—schizophrenia	5.96e-05	0.0012	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—OXT—schizophrenia	5.96e-05	0.0012	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR1A—schizophrenia	5.73e-05	0.00116	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NDST3—schizophrenia	5.7e-05	0.00115	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—NPS—schizophrenia	5.65e-05	0.00114	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NGEF—schizophrenia	5.63e-05	0.00114	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—NPY—schizophrenia	5.61e-05	0.00113	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR2C—schizophrenia	5.54e-05	0.00112	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—DRD1—schizophrenia	5.54e-05	0.00112	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NTS—schizophrenia	5.5e-05	0.00111	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR1B—schizophrenia	5.41e-05	0.00109	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—OXT—schizophrenia	5.41e-05	0.00109	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SLC27A5—schizophrenia	5.41e-05	0.00109	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ACSL6—schizophrenia	5.41e-05	0.00109	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—DRD3—schizophrenia	5.36e-05	0.00108	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR1A—schizophrenia	5.21e-05	0.00105	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—DRD4—schizophrenia	5.21e-05	0.00105	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RGS4—schizophrenia	5.17e-05	0.00104	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRM3—schizophrenia	5.17e-05	0.00104	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RTN4—schizophrenia	5.17e-05	0.00104	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—DAO—schizophrenia	5.16e-05	0.00104	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—NPS—schizophrenia	5.13e-05	0.00104	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR6—schizophrenia	5.08e-05	0.00103	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR2C—schizophrenia	5.03e-05	0.00102	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—DRD1—schizophrenia	5.03e-05	0.00102	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CNR1—schizophrenia	4.97e-05	0.001	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PNP—schizophrenia	4.94e-05	0.000999	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MAG—schizophrenia	4.9e-05	0.00099	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—DRD3—schizophrenia	4.87e-05	0.000983	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—DRD2—schizophrenia	4.85e-05	0.000979	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR7—schizophrenia	4.85e-05	0.000979	CbGpPWpGaD
Tripelennamine—Imipramine—ABCB1—schizophrenia	4.84e-05	0.00281	CrCbGaD
Tripelennamine—Amitriptyline—ABCB1—schizophrenia	4.81e-05	0.00279	CrCbGaD
Tripelennamine—HRH1—Signaling by GPCR—DRD4—schizophrenia	4.73e-05	0.000955	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NDUFV2—schizophrenia	4.6e-05	0.000928	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CNR1—schizophrenia	4.51e-05	0.000912	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CHRM1—schizophrenia	4.48e-05	0.000906	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR7—schizophrenia	4.4e-05	0.000889	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—DRD2—schizophrenia	4.4e-05	0.000889	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL3RA—schizophrenia	4.37e-05	0.000883	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIP4K2A—schizophrenia	4.32e-05	0.000873	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NRG3—schizophrenia	4.26e-05	0.000861	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TLE1—schizophrenia	4.26e-05	0.000861	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GFAP—schizophrenia	4.22e-05	0.000851	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRM5—schizophrenia	4.17e-05	0.000842	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TLE3—schizophrenia	4.04e-05	0.000815	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP26B1—schizophrenia	3.91e-05	0.000789	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCK—schizophrenia	3.81e-05	0.00077	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PDE4B—schizophrenia	3.72e-05	0.00075	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCKAR—schizophrenia	3.66e-05	0.000738	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADORA2A—schizophrenia	3.54e-05	0.000716	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PLA2G4A—schizophrenia	3.49e-05	0.000704	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GCLM—schizophrenia	3.48e-05	0.000704	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TPH1—schizophrenia	3.48e-05	0.000704	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGA—schizophrenia	3.4e-05	0.000686	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—HTR2A—schizophrenia	3.4e-05	0.000686	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NPY—schizophrenia	3.31e-05	0.000669	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ATP2A2—schizophrenia	3.31e-05	0.000669	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOTCH4—schizophrenia	3.31e-05	0.000669	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PRKD1—schizophrenia	3.27e-05	0.000661	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR1B—schizophrenia	3.19e-05	0.000645	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—OXT—schizophrenia	3.19e-05	0.000645	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HTR2A—schizophrenia	3.08e-05	0.000623	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR1A—schizophrenia	3.08e-05	0.000621	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NPS—schizophrenia	3.03e-05	0.000612	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR2C—schizophrenia	2.97e-05	0.0006	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DRD1—schizophrenia	2.97e-05	0.0006	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NTRK2—schizophrenia	2.89e-05	0.000584	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DRD3—schizophrenia	2.88e-05	0.000581	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DRD4—schizophrenia	2.79e-05	0.000564	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GAPDH—schizophrenia	2.73e-05	0.000552	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CLOCK—schizophrenia	2.71e-05	0.000547	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CNR1—schizophrenia	2.67e-05	0.000539	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TPH2—schizophrenia	2.64e-05	0.000533	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CACNB2—schizophrenia	2.64e-05	0.000533	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR7—schizophrenia	2.6e-05	0.000525	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DRD2—schizophrenia	2.6e-05	0.000525	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—DPYD—schizophrenia	2.6e-05	0.000525	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PRL—schizophrenia	2.46e-05	0.000496	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CACNA1C—schizophrenia	2.41e-05	0.000488	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3C2A—schizophrenia	2.35e-05	0.000475	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—S100B—schizophrenia	2.29e-05	0.000462	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ERBB4—schizophrenia	2.19e-05	0.000442	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SNAP25—schizophrenia	2.11e-05	0.000426	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PLA2G4A—schizophrenia	2.06e-05	0.000416	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NRG1—schizophrenia	2.02e-05	0.000408	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MEF2C—schizophrenia	2e-05	0.000404	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—YWHAZ—schizophrenia	1.94e-05	0.000391	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP1A2—schizophrenia	1.91e-05	0.000385	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ERBB3—schizophrenia	1.89e-05	0.000382	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TH—schizophrenia	1.88e-05	0.00038	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HTR2A—schizophrenia	1.82e-05	0.000368	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOE—schizophrenia	1.69e-05	0.000342	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOA1—schizophrenia	1.67e-05	0.000338	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ESR1—schizophrenia	1.62e-05	0.000327	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—COMT—schizophrenia	1.6e-05	0.000323	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTP1—schizophrenia	1.59e-05	0.000321	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MAOA—schizophrenia	1.59e-05	0.000321	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCB1—schizophrenia	1.51e-05	0.000304	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GSK3B—schizophrenia	1.47e-05	0.000296	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PLA2G4A—schizophrenia	1.46e-05	0.000295	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTM1—schizophrenia	1.46e-05	0.000295	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MTHFR—schizophrenia	1.29e-05	0.000261	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOE—schizophrenia	1.2e-05	0.000243	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOA1—schizophrenia	1.19e-05	0.00024	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AKT1—schizophrenia	1.09e-05	0.00022	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AKT1—schizophrenia	9.87e-06	0.000199	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EP300—schizophrenia	9.65e-06	0.000195	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TP53—schizophrenia	6.91e-06	0.00014	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—EP300—schizophrenia	6.86e-06	0.000139	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKT1—schizophrenia	5.83e-06	0.000118	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AKT1—schizophrenia	4.14e-06	8.37e-05	CbGpPWpGaD
